Clinical Utility of Deutetrabenazine as a Treatment Option for Chorea Associated with Huntington's Disease and Tardive Dyskinesia.
Journal Information
Full Title: Ther Clin Risk Manag
Abbreviation: Ther Clin Risk Manag
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Health Care Sciences & Services
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Disclosure SF received salary support as the medical monitor for the TETRA-HD trial and principal investigator for the FIRST-HD and ARC-HD trials. He has served as a consultant to Teva Pharmaceuticals. AA reports no conflicts of interest in this work."
"Disclosure: SF received salary support as the medical monitor for the TETRA-HD trial and principal investigator for the FIRST-HD and ARC-HD trials. He has served as a consultant to Teva Pharmaceuticals. AA reports no conflicts of interest in this work."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025